Inflammation, stress, and diabetes.

Over the last decade, an abundance of evidence has emerged demonstrating a close link between metabolism and immunity. It is now clear that obesity is associated with a state of chronic low-level inflammation. In this article, we discuss the molecular and cellular underpinnings of obesity-induced inflammation and the signaling pathways at the intersection of metabolism and inflammation that contribute to diabetes. We also consider mechanisms through which the inflammatory response may be initiated and discuss the reasons for the inflammatory response in obesity. We put forth for consideration some hypotheses regarding important unanswered questions in the field and suggest a model for the integration of inflammatory and metabolic pathways in metabolic disease.

[1]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[2]  B. Spiegelman,et al.  Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. , 1997, The Journal of clinical investigation.

[3]  R. Evans,et al.  A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .

[4]  M. Lai,et al.  Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. , 2004, The Journal of biological chemistry.

[5]  D. Leroith,et al.  A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. , 2009, The Journal of biological chemistry.

[6]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[7]  K. Petersen,et al.  Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. , 2002, The Journal of clinical investigation.

[8]  C. Dani,et al.  A role for preadipocytes as macrophage‐like cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  N. Haran,et al.  Tumor necrosis factor–α–induced insulin resistance may mediate the hepatitis C virus–diabetes association , 2003, American Journal of Gastroenterology.

[10]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. , 1998, Nature.

[11]  E. Gabazza,et al.  Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. , 2002, Diabetes research and clinical practice.

[12]  Haiyan Xu,et al.  Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. , 2002, Endocrinology.

[13]  G. Sumara,et al.  Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis , 2004, Science.

[14]  D. Altshuler,et al.  The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. , 2003, Annual review of genomics and human genetics.

[15]  G. Blackburn.  Pasteur's Quadrant and malnutrition , 2001, Nature.

[16]  W. Koenig,et al.  Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators , 1998, Nature.

[17]  B. Seed,et al.  PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. , 1998, Nature.

[18]  Y. Nakatani,et al.  The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. , 2005, Diabetes.

[19]  Y. Zick,et al.  Role of Ser/Thr kinases in the uncoupling of insulin signaling , 2003, International Journal of Obesity.

[20]  J. Fernández-Real,et al.  Lower rate of tumor necrosis factor-α −863A allele and higher concentration of tumor necrosis factor-α receptor 2 in first-degree relatives of subjects with type 2 diabetes , 2003 .

[21]  P. Iyengar,et al.  The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.

[22]  M. Barton,et al.  Tumor necrosis factor-alpha levels in adipose tissue of lean and obese cats. , 1998, The Journal of nutrition.

[23]  J. Berger,et al.  Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation , 2003, International Journal of Obesity.

[24]  D. Mangelsdorf,et al.  Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Jerrold M. Olefsky,et al.  Diabetes mellitus : a fundamental and clinical text , 2004 .

[26]  I. McInnes,et al.  Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. , 2003, Circulation.

[27]  Stephen R. Bloom,et al.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.

[28]  H. Lodish,et al.  Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. , 2003, The Journal of biological chemistry.

[29]  L. Makowski,et al.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. , 2004, The Journal of nutrition.

[30]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[31]  K. Rajewsky,et al.  Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. , 2004, The Journal of clinical investigation.

[32]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[33]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[34]  C. Scheidereit,et al.  NF-kappaB and the innate immune response. , 2000, Current opinion in immunology.

[35]  M. Lai,et al.  Endoplasmic Reticulum Stress Stimulates the Expression of Cyclooxygenase-2 through Activation of NF-κB and pp38 Mitogen-activated Protein Kinase* , 2004, Journal of Biological Chemistry.

[36]  S. E. Brodie.  New York, New York, USA , 1996 .

[37]  M. Lazar,et al.  The current biology of resistin , 2004, Journal of internal medicine.

[38]  K. Wellen,et al.  Interaction of Tumor Necrosis Factor-α- and Thiazolidinedione-Regulated Pathways in Obesity , 2004 .

[39]  R. Evans,et al.  PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. , 1998, Cell.

[40]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[41]  M. Reilly,et al.  An Inflammatory Cascade Leading to Hyperresistinemia in Humans , 2004, PLoS medicine.

[42]  A. Saltiel,et al.  Insulin signaling pathways in time and space. , 2002, Trends in cell biology.

[43]  K. Moulder,et al.  Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells (*) , 1995, The Journal of Biological Chemistry.

[44]  H. Kaneto,et al.  Modulation of the JNK Pathway in Liver Affects Insulin Resistance Status* , 2004, Journal of Biological Chemistry.

[45]  K. Rajewsky,et al.  Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance , 2004 .

[46]  C. Kahn,et al.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.

[47]  Peter Tontonoz,et al.  Reciprocal regulation of inflammation and lipid metabolism by liver X receptors , 2003, Nature Medicine.

[48]  G. Cheng,et al.  Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. , 2003, Molecular cell.

[49]  R. Chandra.  Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice. , 1980, The American journal of clinical nutrition.

[50]  S. Shoelson,et al.  Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. , 2003, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[51]  S. Cameron,et al.  Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor , 2001, The Journal of Biological Chemistry.

[52]  B. Spiegelman.  PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. , 1998, Diabetes.

[53]  Graham M Lord,et al.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.

[54]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[55]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[56]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2004, Molecular and Cellular Biology.

[57]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[58]  A. Yoshimura,et al.  Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity , 2004, Nature Medicine.

[59]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[60]  M. Quon,et al.  Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. , 2004, Molecular endocrinology.

[61]  W. Koenig,et al.  Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. , 1998, Nature.

[62]  M. Hammami.  Diabetes Mellitus: A Fundamental and Clinical Text , 1997 .

[63]  G. Magni,et al.  Molecular Cloning, Chromosomal Localization, Tissue mRNA Levels, Bacterial Expression, and Enzymatic Properties of Human NMN Adenylyltransferase* , 2001, The Journal of Biological Chemistry.

[64]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[65]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[66]  Jianping Ye,et al.  Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. , 2002, The Journal of biological chemistry.

[67]  Dallas Jones,et al.  Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.

[68]  R. Hanson,et al.  The interleukin-6 (−174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians , 2003, Human Genetics.

[69]  S. Akira,et al.  Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.

[70]  Qing Yang,et al.  Interaction of tumor necrosis factor-alpha- and thiazolidinedione-regulated pathways in obesity. , 2004, Endocrinology.

[71]  M. White,et al.  The insulin signalling system and the IRS proteins , 1997, Diabetologia.

[72]  Peter Tontonoz,et al.  LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response , 2004, Cell.

[73]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[74]  E. Van Obberghen,et al.  SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice* , 2001, The Journal of Biological Chemistry.

[75]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[76]  W. Ricart,et al.  Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes. , 2003, Metabolism: clinical and experimental.

[77]  Jianping Ye,et al.  Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex* 210 , 2002, The Journal of Biological Chemistry.

[78]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[79]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[80]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[81]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[82]  G. Hotamisligil,et al.  The role of TNF alpha in adipocyte metabolism. , 1999, Seminars in cell & developmental biology.

[83]  C. Schmitz‐Peiffer.  Protein Kinase C and Lipid‐Induced Insulin Resistance in Skeletal Muscle , 2002, Annals of the New York Academy of Sciences.

[84]  Peter Olson,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0288 Minireview: Lipid Metabolism, Metabolic Diseases, and , 2022 .

[85]  J. Flier,et al.  Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 , 2004, Nature Medicine.

[86]  R. Chandra.  Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[87]  R. Evans,et al.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. , 2001, Molecular cell.

[88]  N. Socci,et al.  Leptin-specific patterns of gene expression in white adipose tissue. , 2000, Genes & development.

[89]  M. Schwartz,et al.  Genetics and pathophysiology of human obesity. , 2003, Annual review of medicine.

[90]  Keita Kono,et al.  Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. , 2005, Cell metabolism.

[91]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[92]  Mireille André,et al.  Preadipocyte Conversion to Macrophage , 2003, The Journal of Biological Chemistry.

[93]  K. Petersen,et al.  Mitochondrial dysfunction and type 2 diabetes , 2005, Current diabetes reports.

[94]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[95]  H. Lodish,et al.  Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB* , 2003, Journal of Biological Chemistry.

[96]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[97]  J. Lehmann,et al.  An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.

[98]  M. Czech,et al.  An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. , 2004, Genes & development.

[99]  Carlos Iribarren,et al.  Are patients with asthma at increased risk of coronary heart disease? , 2004, International journal of epidemiology.

[100]  H. Kaneto,et al.  Involvement of Endoplasmic Reticulum Stress in Insulin Resistance and Diabetes* , 2005, Journal of Biological Chemistry.

[101]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[102]  C. Dina,et al.  The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes , 2000, Nature Genetics.

[103]  H. Kaneto,et al.  Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide , 2004, Nature Medicine.

[104]  J. Olefsky,et al.  TNF-α-Induced Insulin Resistance In Vivo and Its Prevention by Troglitazone , 1997, Diabetes.

[105]  J. Lehmann,et al.  An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). , 1995, The Journal of biological chemistry.

[106]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[107]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[108]  S. Shoelson,et al.  Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance , 2003, International Journal of Obesity.

[109]  Jong Bae Seo,et al.  Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor γ Expression , 2004, Molecular and Cellular Biology.

[110]  K. Moore,et al.  Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.

[111]  John J. Shin,et al.  Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights , 2004, Current diabetes reports.

[112]  M. Lafontan,et al.  Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. , 2001, Diabetes.

[113]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[114]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[115]  William A. Boisvert,et al.  Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.

[116]  S. Kihara,et al.  Obesity, adiponectin and vascular inflammatory disease , 2003, Current opinion in lipidology.

[117]  R. Unger,et al.  Role of nitric oxide in obesity-induced beta cell disease. , 1997, The Journal of clinical investigation.

[118]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[119]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[120]  D. Brown,et al.  Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. , 1978, The Journal of clinical investigation.

[121]  JoAnn E Manson,et al.  Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. , 2004, Diabetes care.

[122]  A. Marette,et al.  Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle , 2001, Nature Medicine.

[123]  B. Seed,et al.  PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.

[124]  Haiyan Xu,et al.  Exclusive Action of Transmembrane TNFα in Adipose Tissue Leads to Reduced Adipose Mass and Local But Not Systemic Insulin Resistance. , 2002, Endocrinology.

[125]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[126]  K. Petersen,et al.  Cellular mechanism of insulin resistance: potential links with inflammation , 2003, International Journal of Obesity.

[127]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[128]  I. Caterson,et al.  Association of the TNF-α−308 G/A Promoter Polymorphism with Insulin Resistance in Obesity , 2002 .